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Abstract
The putamen has a somatotopic organization of neurons identified by correspondence of firing rates with selected body
part movements, as well as by complex, but organized, differential cortical projections onto putamen. In isolated focal
dystonia, whole putaminal binding of dopamine D2-like receptor radioligands is quantitatively decreased, but it has not
been known whether selected parts of the putamen are differentially affected depending upon the body part affected by
dystonia. The radioligand [18F]spiperone binds predominantly to D2-like receptors in striatum. We hypothesized that the
spatial location of [18F]spiperone binding within the putamen would differ in patients with dystonia limited to the hand
versus the face, and we tested that hypothesis using positron emission tomography and magnetic resonance imaging. To
address statistical and methodological concerns, we chose a straightforward but robust image analysis method. An
automated algorithm located the peak location of [18F]spiperone binding within the striatum, relative to a brain atlas, in
each of 14 patients with cranial dystonia and 8 patients with hand dystonia. The mean (left and right) |x|, y, and z
coordinates of peak striatal binding for each patient were compared between groups by t test. The location of peak
[18F]spiperone binding within the putamen differed significantly between groups (cranial dystonia z,hand dystonia z,
p= 0.016). We conclude that in isolated focal dystonia, dopamine D2-like receptors are distributed differently in the
putamen depending on the body part manifesting dystonia.
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Introduction
Dystonia is a clinical syndrome of involuntary muscle contrac-
tions producing either sustained or intermittent abnormal postures
of different body parts [1]. Dystonia may be associated with other
neurologic abnormalities or may occur as an isolated manifesta-
tion. The isolated dystonias (previously known as primary
dystonias) are a diverse group of disorders characterized by
involuntary, sustained muscle contractions that may cause twisting
and repetitive movements, sustained movements or abnormal
postures. These isolated dystonias typically begin in different body
parts. Two examples of focal isolated dystonia are cranial dystonia,
with sustained involuntary eyelid closure frequently associated
with lower facial grimacing, and hand cramp, with excessive co-
contractions of agonist and antagonist hand or forearm muscles
during specific tasks such as writing.
The pathophysiology of isolated dystonia is only partially
understood [2,3,4,5,6]. However, dopamine D2-like receptor
binding in the putamen is abnormally low [2,7,8,9,10,11].
Although the neurological manifestation may be focal, it is unclear
whether the decrease in D2-like binding is uniform throughout the
putamen or whether it is somatotopically related to the body part
affected. In other words, D2-like receptors may be more affected
in a part of the putamen, corresponding to the focal change in
behavior.
We investigated this question by comparing the spatial
distribution of [18F]spiperone binding in patients with cranial
dystonia to the distribution in patients with hand cramp. We
hypothesized that if the focal distribution of clinical signs
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corresponded to a focal abnormality of the putamen, then the




The study was approved by the Washington University Human
Studies Committee, and all subjects gave written informed
consent.
Patients
A movement disorders specialist examined all subjects and
made the diagnosis of isolated cranial dystonia (with predominant
involuntary eyelid squeezing and excessive blinking) or isolated
hand dystonia based upon typical clinical characteristics [1,12].
Each person also completed the Edinburgh Handedness Inventory
[13], Mini-Mental State Examination [14], and Hamilton
Depression Rating Scale [15]. Exclusion criteria included evidence
of dementia, depression, dystonia affecting any other part of the
body, drug abuse, other neurologic illness or exposure to drugs
known to affect dopamine receptors. There were 14 patients with
cranial dystonia (1 left-handed, 10 women, median age 54.5, range
46–79), and 8 patients with hand cramp (2 left-handed, 6 women,
median age also 54.5, range 25–68). In the hand cramp patients,
dystonia affected the writing (dominant) hand predominantly or
exclusively. Detailed clinical characteristics of 20 of the 22 subjects
were included in a prior report (rows 2–21 in Table 1, ref. [7]).
This study adds a 77-year-old right-handed man with blepharo-
spasm for 12 years, taking captopril and theophylline, with
botulinum toxin injections 6 months before PET, and a 61-year-
old right-handed woman with hand cramp for 12 years, taking
estrogens, ergotamine tartrate, caffeine and ibuprofen the day
before PET with botulinum toxin injections 3 months before. In a
secondary analysis, we examined data from 10 healthy control
subjects who were studied contemporaneously using the same
methods (1 left-handed, 5 women, median age 63.5, range 24–76).
Magnetic Resonance Image (MRI) Acquisition
Sagittal MPRAGE (TR=9.7 ms, TE= 4 ms, and flip an-
gle = 12u) images were acquired with a 1.5T Siemens Magnetom
scanner [16]. The 3D field of view was 25662566160 mm with
voxel dimensions 16161.25 mm. The main field was shimmed
and the transmitter tuned before each study.
Radioligand
[18F]Spiperone was prepared using a microwave-facilitated
synthetic pathway [17]. The radiopharmaceutical had $95%
radiochemical purity and a specific activity $2000 Ci/mmol.
Positron Emission Tomography (PET) Image Acquisition
PET data were acquired with a Siemens ECAT 953b camera in
the 2D wobble mode. The spatial characteristics of this instrument
have been extensively documented [18,19]. In the 2D wobble
mode it produces 31 2D images with an intrinsic resolution of
approximately 5.4 mm (full width half maximum; FWHM) in
plane and 4.2 mm axially. Three to 5 mCi of [18F]spiperone was
injected intravenously, and PET scans began immediately with
tracer injection. Scan lengths began at 60 seconds and increased to
10 minutes, for a total of 3 hours. During the scan, patients were at
rest with eyes closed in a quiet, darkened room. They were
observed frequently and had essentially no dystonic movements
during the scan. The images were reconstructed with a ramp filter
using attenuation measured by an external 68Ge/68Ga source.
Image Processing: Overview
The reconstructed PET images were corrected for inter-scan
head movement and registered to a standard atlas [20] using the
procedure described below. This procedure yielded, for each
subject, an atlas-transformed [18F]spiperone PET image weighted
to reflect specific binding (‘‘late image’’). The late images then
were used to examine diagnosis-dependent changes in putaminal
[18F]spiperone distribution. Although only the late images were
analyzed for group differences in [18F]spiperone activity, all the
acquired PET data were used in computing the PET-MRI image
registrations, to maximize the reliability of this critical step ( [21];
see also Supplementary Information in ref. [22]).
Preliminary PET Image Processing
The decay-corrected, reconstructed PET data acquired during
each 3 hour scan were divided into 18 frames, each frame
representing 10 minutes of scanning. (The first 3 such frames were
created by simple addition of data originally acquired in 2- or 5-
minute bins). We called the first 7 ten-minute frames ‘‘early’’ and
the last 3 ten-minute frames ‘‘late’’, leaving 8 ‘‘middle’’ frames.
The cutoff times dividing these three groups were chosen to give
images on which tracer distribution primarily reflected blood flow
(early) or specific binding (late) (see Discussion and refs. [23,24]).
All frames within each group were aligned to the middle frame of
that group by rigid body (6 parameter affine) transformations using
difference image variance minimization as the objective function
[25]. Early, middle and late composite images then were produced
by conventional resampling and averaging using 3D linear
interpolation.
PET-MRI Alignments
The early, middle and late composite PET images and the MP-
RAGE image were mutually coregistered. Rigid body alignments
corresponding to all image pairs within the group were computed
using, as the objective function, a variant of the image intensity
gradient correlation method of Andersson et al. [26]. On the basis
of these alignments, rigid body transforms were computed
bringing each of the 3 composite PET images into register with
the MP-RAGE. Translational and rotational alignment inconsis-
tency was estimated by comparing the transforms relating each
pair of images. The estimated transform inconsistency typically
was only ,0.3 root mean square (rms) mm total for translation
and ,0.3 rms degree total for rotation. In no case did these
quantities exceed 0.5 rms mm or 0.5 rms degree.
Atlas Transformation
Each subject’s MRI was transformed to atlas space by
optimizing the linear fit to an atlas target image [20,25]. Finally,
Table 1. Mean location in atlas space of peak [18F]spiperone
binding, by group (mm).
|x| y z
cranial dystonia 23.9 0.4 2.8
hand cramp 24.5 0.5 4.9
p 0.372 0.977 0.016
control subjects 24.8 21.4 4.4
doi:10.1371/journal.pone.0088121.t001
Putaminal D2R Distribution in Focal Dystonias
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the late PET image was transformed into atlas space by matrix
multiplication and trilinear interpolation. The accuracy of this
method has been demonstrated [22,27,28].
Peak Search and Statistics
For each subject, the late image was smoothed to 7 mm final
FWHM resolution using a Butterworth filter, and then searched
with an automated algorithm which reports the center of mass of
intensity peaks in the image [29]. Center of mass was computed
over a spherical volume of interest with 6 mm radius (see Figure 1
for an example). The coordinates of peak activity in left and right
putamen were averaged for each subject using the absolute value
of the x coordinate. For the cranial dystonia patients no ‘‘worse
side’’ can be identified and no left-right difference would be
predicted, and many patients with unilateral hand cramp have
bilateral physiologic abnormalities [30,31,32]. The mean |x|, y,
and z coordinates in cranial vs. hand dystonia were compared
using unpaired t-tests. We report uncorrected p values since the
three coordinates are not independent, but note that the
conservative Bonferroni correction would accept p,0.017 as
significant.
Results
The peak location of putaminal [18F]spiperone binding differed
significantly between groups (see Table 1 and Figure 2). Descrip-
tively, the cranial dystonia subjects’ peaks were more medial,
anterior and inferior than the hand cramp patients’, but only the z
dimension difference was statistically significant.
Since patients in the two dystonia groups could not be perfectly
matched by age, we examined whether a difference in mean age
was likely to account for the results. This was performed by
plotting peak z coordinate versus age in a separate group of
normal volunteers; images were analyzed exactly as for the
dystonia patients. As shown in Figure 3, in this small sample there
is no evidence for an age effect (Pearson’s r=20.1). Furthermore,
from the best linear fit to this data, the predicted z value for the
mean age (61.3) of the cranial dystonia patients is 4.3, while the
predicted z value for the mean age (51.6) of the hand cramp
patients is 4.4. The observed difference between the two dystonia
groups is 21 times greater than this small difference attributable to
age.
Discussion
The spatial distribution of [18F]spiperone binding in the
putamen differs in cranial and hand dystonia. This demonstrates
Figure 1. Matched coronal sections from the MP-RAGE (top) and late image (bottom) for one subject. The lines in each image cross at
the location of peak putaminal [18F]spiperone binding in this subject.
doi:10.1371/journal.pone.0088121.g001
Putaminal D2R Distribution in Focal Dystonias
PLOS ONE | www.plosone.org 3 February 2014 | Volume 9 | Issue 2 | e88121
differential spatial distribution of receptors within the putamen
corresponding to localized behavioral manifestation of dystonia.
We and others have shown that average D2-like binding over
the whole putamen is 25–30% lower in isolated focal dystonia than
in normal controls [7,8,9,10,11]. (Increased binding of certain D2-
like ligands in dopa-responsive dystonia is not comparable, as these
ligands are displaceable by dopamine, so decreased dopamine
synthesis increases their binding even if receptors are normal
[33,34,35] or decreased [36].) Decreased D2-like receptor binding
corresponds to numerous other suggestions that dopaminergic
dysfunction may be involved in the pathophysiology of focal
dystonias [2,3,4,6,37,38,39].
What has not been clear is whether this decrease is homoge-
neous throughout the putamen. If so, other factors would
presumably determine which body part manifests dystonic
symptoms. This is consistent with the notion of a ‘‘two-hit’’
animal model of dystonia [40,41,42]. Alternatively, different focal
dystonias in humans might all feature an average decrease in
putaminal D2-like receptor binding, but changes in the distribu-
tion of D2-like receptors within the putamen might dictate which
body parts were affected. The present study reveals a difference in
the spatial distribution of D2-like receptors between patients with
dystonia affecting the hand or face, and we speculate that the
difference may prove to be somatotopic.
Several lines of evidence indicate that there is a somatotopic
organization in the putamen [43]. Pathway anatomy in monkeys
has shown that projections from the face, arm, and leg
representations in somatosensory and motor cortex terminate in
a topographic pattern that preserves the somatotopic separation of
these body areas [44,45,46,47,48,49,50]. The somatotopic ar-
rangement is such that the legs are represented laterally, anteriorly
and dorsally in the putamen, the face is represented medially,
posteriorly and ventrally, and the arm is represented between these
(Figure 4). The somatotopy has been confirmed by studies of
neuronal activity related to movement of different body parts and
by activation of discrete movements by microstimulation in
different areas in putamen [46]. The presence of somatotopy in
the human putamen has been shown with functional MRI blood
oxygen level dependent (BOLD) activation during self-paced
flexion-extension of fingers or toes [51].
The work of Graybiel and colleagues has indicated that the
anatomical relationship between somatotopically identified regions
of cerebral cortex and putamen is not simple [49]. One area of
cortex projects to multiple areas in putamen, and closely related
cortical areas (e.g. thumb and fifth finger representations) project
to overlapping areas. Thus, there are convergent and divergent
projections in the corticostriatal projection [52]. However,
projections from non-adjacent body part representations in cortex
have little or no overlap in putamen. Thus, despite the complex
pattern and multiple representations, face, arm and leg are
represented separately. These non-overlapping representations
conform to the overall organization described above with leg
dorsal, lateral, and anterior to face, and arm in between.
Delmaire and colleagues [53] demonstrated that this normal
somatotopic representation in putamen was disrupted in patients
with writer’s cramp (task-specific isolated focal dystonia of the
hand). In healthy control subjects, repetitive movements of the toes
led to BOLD activation in the superior part of the contralateral
putamen, lip movements activated the inferior putamen, and
finger movement activation in the putamen was between them. By
contrast, writer’s cramp patients had no such gradient. As in the
present study, the abnormality was limited to the superior-inferior
axis.
Several limitations of our work should be addressed. The precise
nature of the group difference in distribution of radiotracer
binding is not revealed by the methods chosen for this study. Since
overall putaminal D2R binding is decreased in focal dystonias, one
would like to know whether focal decreases in [18F]spiperone
binding exist and where they are located within the putamen.
Thus a search for a local minimum in [18F]spiperone binding in
putamen might seem more intuitive. However, numerical searches
for local minima in a small region of high signal are likely to
identify the putaminal boundary. Another approach would be to
compare [18F]spiperone binding at each voxel. However, given the
available number of subjects and the high image variance, we did
Figure 2. Coronal view of peak [18F]spiperone binding in
striatum in cranial and hand dystonia. The location of peak
[18F]spiperone binding in striatum is plotted for each dystonic subject
by atlas |x| and z coordinates according to which part of the body is
affected by dystonia. On average, the peak was 2.1 mm more superior
in the hand cramp group (red triangles) than in the group with dystonia
affecting the face (blue circles). The mean location for each dystonia
group is indicated by a plus sign; note that the mean (and median)
cranial dystonia peak lies inferior to every hand cramp peak. The three
left-handed subjects are indicated by dashed symbols. The large black
lines intersect at the mean peak location for the control group.
doi:10.1371/journal.pone.0088121.g002
Figure 3. Peak putaminal [18F]spiperone binding does not vary
significantly with age. The location of peak [18F]spiperone binding in
striatum (atlas z coordinate) is graphed versus age, for a group of
normal volunteers. There is no meaningful correlation of this measure
with age, and the line that best fits the data has a nearly flat slope.
doi:10.1371/journal.pone.0088121.g003
Putaminal D2R Distribution in Focal Dystonias
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not predict adequate power to find a group difference while
correcting for multiple comparisons at ,1000 voxels [54].
Furthermore, the normal spatial distribution of [18F]spiperone
binding within the putamen is not well characterized at the
resolution of PET. Finally, one would like to know whether
receptor binding at a given voxel is quantitatively lower or higher
than normal. Unfortunately, the counting statistics in [18F]spiper-
one PET images are inadequate to confidently quantify absolute
radioligand binding on a pixel-by-pixel basis using validated tracer
kinetic analysis techniques. Faced with these difficulties, we chose
to characterize the spatial distribution of radiotracer using a
straightforward and reliable method, namely location of peak
binding in a radiographic image. This method provided adequate
statistical power to verify our main hypothesis that putaminal D2-
like dopamine receptors are distributed differently in patients with
dystonia in different body parts. However, these advantages were
bought at a price: this method does not permit us to identify the
location in putamen most pertinent to pathophysiology, or to
clarify whether the binding at the identified peak is abnormally
high or low in either patient group compared to normal. Still, we
have shown that there is a difference in D2-like receptor
distribution between cranial dystonia and hand cramp.
We use the ‘‘late’’ image alone to make inferences about the
location of receptor binding, rather than apply a full tracer analysis
to quantify radioligand binding [24,55]. This is valid in the present
context. For valid comparisons of radioligand specific binding
between two groups, it is necessary to apply a tracer kinetic model
that includes measurements of not only regional radioligand
concentration but also regional blood flow, blood volume, time-
dependent measures of radioactivity in arterial blood and the
accumulation of radiolabeled metabolites. Using these data and
parameter estimation methods, it is possible to estimate specific
binding of the radioligand binding [7,23,24]. However, the present
analysis does not require these additional steps, since the
peripheral blood measurements are the same for analyzing every
part of the putamen, and the small differences that could exist in
blood flow and blood volume in different parts of the putamen
would not appreciably affect the estimate of radioligand binding
[55]. Therefore, identifying the location of peak radioactivity in a
single subject is equivalent to identifying the location of peak
radioligand binding in that subject, but does not provide an
absolute measure of specific binding that would permit quantita-
tive comparisons across subject groups.
Using the whole brain to compute atlas registration improves
reliability since there is more data upon which to perform the co-
registration, but may be less sensitive to additional changes in
receptor distribution which might be detected by a putamen-only
atlas. Also, although our results most likely reflect differences in
dopamine receptors, only about 70% of [18F]spiperone specific
binding sites in primate striatum are attributable to D2-like
dopamine receptors with the remainder composed of serotonin S2
receptors [24]. At the time that these studies were performed,
[18F]spiperone was the only D2-like radioligand available to us;
more robust receptor measurements may be possible using the D2-
specific radioligand (N-methyl)benperidol [56,57]. An additional
potential limitation in interpreting our results is that the different
location of peak binding could reflect either neurochemical or
anatomical differences between groups. However, an MRI study
in these patients showed no group difference in putamen volume
[54], suggesting that the difference is likely to reflect altered
receptor distribution rather than anatomical changes. In this study
we cannot resolve whether the observed differences in striatal
[18F]spiperone binding are involved in the production of
symptoms or whether they arise in response to the repeated
dystonic movements; however, results in a rodent model and in
human non-manifesting DYT1 gene carriers are more consistent
with the former possibility [10,58]. Additionally, a recent study
suggests that D3 rather than D2 receptors may be responsible for
the abnormal putaminal D2-like receptor binding in focal dystonia
[57]. Nevertheless, all these issues are tangential to the main
finding of a receptor difference in putamen that corresponds to a
focal difference in behavior.
In conclusion, patients with dystonia affecting different body
parts have a different spatial distribution of [18F]spiperone binding
in the putamen that may reflect the previously demonstrated
somatotopic organization of putamen. This demonstrates that
focal behavioral manifestations of disease can correspond to focal
neurotransmitter receptor changes in striatum.
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